Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
NOF CORPORATION v. Nektar Therapeutics
Case Number:
Case Type:
IPR
Status:
Final Written Decision
Petitioner:
NOF CORPORATION
Patent Owner:
Nektar Therapeutics
Tech Center:
1600
-
August 02, 2021
PTAB Axes Patent Claims For Nektar Hemophilia Drug
The Patent Trial and Appeal Board has found that claims in two polymer patents that cover a hemophilia treatment developed by Nektar Therapeutics are obvious in light of a collection of prior art.
-
March 09, 2020
PTAB Says Bayer Not Real Party In 3 Institution Decisions
In a series of three redacted institution decisions from February that were unsealed Friday, the Patent Trial and Appeal Board rejected Nektar Therapeutics' argument that NOF Corporation's petitions should be denied because they failed to name Bayer as a real party in interest.